The Food and Drug Administration yesterday announced a firmware update to reduce the risk of rapid battery depletion and address cybersecurity vulnerabilities in certain Abbott devices that provide pacing for slow heart rhythms and electrical shock or pacing to stop dangerously fast heart rhythms. The update applies to several families of Abbott (formerly St. Jude Medical) implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators, including certain devices included in a 2016 recall related to premature battery depletion. FDA recommends that all eligible patients receive the firmware update at their next regularly scheduled visit or when appropriate, depending on the preferences of the patient and physician. Firmware is a type of software embedded in the hardware of a medical device.

Related News Articles

Headline
A joint advisory issued the week of July 8 by the Cybersecurity and Infrastructure Security Agency, National Security Agency, FBI and several international…
Headline
The AHA July 2 submitted comments to the Cybersecurity and Infrastructure Security Agency on its proposed rule establishing reporting requirements for…
Headline
The Department of Health and Human Services Health Sector Cybersecurity Coordination Center June 27 issued an alert about a critical vulnerability in MOVEit, a…
Headline
A joint report released June 26 by the Cybersecurity and Infrastructure Security Agency, FBI, the Australian Cyber Security Centre and Canadian Centre for…
Headline
The Health Information Sharing and Analysis Center June 27 issued a threat bulletin alerting the health sector to active cyberthreats exploiting TeamViewer. H-…
Headline
The FBI and Department of Health and Human Services June 24 released an advisory about cyberthreat actors targeting health care organizations in attempts to…